Immunoglobulins Anti Platelets In Breast Milk Of Maternal ITP
NCT01880801 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 22
Last updated 2013-06-19
Summary
The purpose of this study is to determine whether mothers with Idiopathic thrombocytopenic purpura (ITP) has antibodies against platelets in breastfeeding milk aside control group of healthy mothers.
In order to prevent severe thrombocytopenia in infants born to mothers with ITP.
Conditions
- Mothers With ITP Condition
Sponsors & Collaborators
-
Laniado Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-08-31
- Primary Completion
- 2014-08-31
- Completion
- 2014-08-31
Countries
- Israel
Study Locations
More Related Trials
-
An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers
NCT00005570 ·Status: COMPLETED
-
Retrospective & Prospective Observational Study of Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
NCT00454857 ·Status: COMPLETED
-
Platelet Function in Idiopathic Thrombocytopenic Purpura (ITP) Patients With Eltrombopag
NCT00888901 ·Status: COMPLETED ·Phase: PHASE4
-
Explore the Relationship Between Platelet Count and Bleeding Score in ITP
NCT06273956 ·Status: RECRUITING
-
The Outcome of the Thrombopoietin Receptor Agonists in Pediatric Patient With Persistent or Chronic ITP Unresonsive to Steroids
NCT06568913 ·Status: RECRUITING ·Phase: NA
-
NATURAL KILLER CELLS IN IMMUNOLOGIC THROMBOCYTOPENIC PURpura of Adults
NCT01172015 ·Status: COMPLETED ·Phase: NA
-
Role of CD11a in Pathogenesis of Primary ITP and Effect of Immunosuppressive Therapy on Its Level
NCT03864796 ·Status: COMPLETED
-
Efficacy and Safety of IVIG-L in ITP Patients
NCT00151840 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Chronic Immune Thrombocytopenic Purpura (ITP) With Intravenous Immunoglobulin IgPro10
NCT00168038 ·Status: COMPLETED ·Phase: PHASE3
-
Immune Markers in Pediatric ITP on Second Line Therapy
NCT06093529 ·Status: NOT_YET_RECRUITING
-
Immunological Markers in Adult Patients With Immune Thrombocytopenic Purpura
NCT04056507 ·Status: COMPLETED
-
Longitudinal Cohort of Pediatric Primary Immune Thrombocytopenia (ITP)
NCT06107582 ·Status: RECRUITING
-
Use of Rituximab Treatment in Addition to Standard Care for Newly Presenting Thrombotic Thrombocytopenic Purpura
NCT00251277 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Thrombopoietin Agonists in Patients With Idiopathic Thrombocytopenic Purpura
NCT06137105 ·Status: NOT_YET_RECRUITING
-
The Association Between Platelet Reactivity and Bleeding Risk in Adult ITP
NCT03377439 ·Status: UNKNOWN
-
Platelet Glycoproteins in Inherited Thrombocytopathy: Association With Aggregation Studies and Bleeding Severity
NCT03648190 ·Status: UNKNOWN
-
Lymphocyte Counts in Immune Thrombocytopenic Purpura
NCT03244410 ·Status: UNKNOWN
-
Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body.
NCT01520909 ·Status: COMPLETED ·Phase: PHASE3
-
"Cytotoxic T Lymphocyte-Associated Antigen-4 (CTLA-4) Gene Single-nucleotide Polymorphism in Primary Immune Thrombocytopenic Purpura in Children"
NCT07014904 ·Status: NOT_YET_RECRUITING
-
Anti-CD38 Antibody Treating Pediatric Primary Immune Thrombocytopenia (ITP)
NCT06168851 ·Status: RECRUITING ·Phase: PHASE2
-
Cohort of Children With Acute Immune or Idiopathic Thrombocytopenic Purpura (ITP) : a Prospective Study in Pays De La Loire
NCT00331357 ·Status: UNKNOWN
-
Viral Hepatitis B and C Infection in Patients With Idiopathic Thrombocytopenic Purpura Treated With Triple Therapy
NCT04113915 ·Status: UNKNOWN
-
Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias.
NCT01933035 ·Status: COMPLETED
-
Efficacy and Safety Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Adult Subjects With Chronic Idiopathic Thrombocytopenic Purpura
NCT00162006 ·Status: COMPLETED ·Phase: PHASE2
-
Milk-only Lactation Study for Patients on Eltrombopag
NCT01055600 ·Status: WITHDRAWN ·Phase: PHASE4